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ABSTRACT

The Effects of Jasmonates on the Proliferation of Human
Prostate Cancer Cell Lines in Culture

by
Daniel Emeka Ezekwudo
J. Abiodun E l e g b e d e ,P h .D ., Examination CommitteeChair/Advisor
Assistant Professor of Biochemistry
University of Nevada, Las Vegas

Jasmonic acid

(J A ) , cis-Jasmone

(CJ), and Methyl jasmonate

(MJ), belong to a family of plant stress hormones known as
the jasmonates.

In plants,

these compounds function as

activators of cellular responses to diverse situations
including cell death.

Proliferation and cytotoxicity

assays showed that the jasmonates inhibited the
proliferation of the prostate cancer cell lines
DU-145),

cultured in vitro.

In addition,

(PC-3 and

the type of

inhibition exhibited by these agents was analyzed using
flow cytometry

(BrdU assay and Annexin V-FITC/PI

and fluorescence microscopy.

staining)

The mechanism of inhibition

111
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was studied using 5-lipoxygenase enzyme.
JA and MJ)

All agents

(CJ,

inhibited proliferation of the cells in dose-

and kinetic-dependent manners.

All the assays confirmed

that the inhibition was through the induction of apoptosis
and that the m echanism of inhibition may involve the 5lipoxygenase pathway.

The results indicated a potential

role for these compounds in the treatment of human prostate
cancer.
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CHAPTER 1

INTRODUCTION
Cancer is a disease condition in which abnormal cells
grow without control as either benign or malignant tumors.
In most cases,

this often results in death.

At present,

there is no clear understanding as to what constitute the
causal factors

for this disease;

however,

some causal

factors have been categorized into sporadic and congenital
factors.

Sporadic factors are those causal factors that

are associated with the individual's way of life such as
smoking and exposure to chemicals or radiation.

Congenital

factors on the other hand involve those causal factors that
are genetically controlled and can be transferred from the
parents to the offsprings.

Congenital factors include

inherited mutations in the genes that can affect the immune
condition as well as the hormone function of an individual.
The time it takes for cancer to fully manifest in an
individual varies depending on the type of cancer involved
therefore giving enough treatment opportunities using
surgery,

chemotherapy,

radiation,

cryotherapy,

hormone
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therapy or a combination of two or more of these options.
However,

due to side effects resulting from some of these

treatment options,

it becomes important to look into the

role of natural plant compounds in the treatment of these
cancers since these compounds are less toxic and are
usually present in food consumed by humans.

1.1

Purpose of the study/Research question

Naturally occurring phytochemicals have been used in
cancer treatment.
[1]

For instance,

in 1984,

first reported that the monoterpene,

Elegbede et al.
d-limonene,

inhibited the development of chemically-induced mammary
tumors in rats.

Later,

Elegbede et al.

[2] reported that

d-limonene caused the regression of frank mammary tumors in
laboratory rats.

In another study,

by Vij

and Kumar

[3],

Asian men were observed to have less prostate cancer
incidence and mortality rate than American men;

this was

attributed to the type of food being consumed in those
areas.

In another cohort study by Kumar et al.

[4], they

found that when prostate cancer patients that are still at
the early stages of the disease are supplemented with
isoflavones

(a phytochemical),

serum prostate-specific antigen

there was a reduction in
(PSA)

in a large number of these patients

and free testosterone

[4].

The mechanisms of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

action the phytochemicals on cancer cells have not been
fully understood.

However,

isoflavones and estrogens have

been shown to inhibit the proliferation of prostate tumors
by competitively interfering with the action of
testosterone

(a hormone that has been implicated in

prostate cancer progression)

[3, 4].

These phytochemicals

influence the action of testosterone by increasing the
level of sex hormone-binding globulin that binds
testosterone,

resulting in lower free testosterone levels

and subsequent decrease in the rate of prostate cancer
stimulation

[5].

Prostate cancer has been shown to be hormonedependent,

that is,

an increase in the level of serum

testosterone will result in an increase in the rate of
prostate cancer proliferation

j.6].

Based on this fact,

hormone therapy is viewed by many researchers as what might
bring an end to the ordeal experienced by prostate cancer
patients.

As explained later in this chapter,

hormone

therapy has been used to treat prostate cancer patients who
are resistant to chemotherapy or other treatment options
and those that are still at the locally advanced stage of
the disease.

However,

a lot of side effects have been

experienced with this treatment option
side effects,

[61.

Due to these

there is a need for research into other

3
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possible ways through which this disease can be eliminated
or reduced.
Therefore,

we proposed to study the chemotherapeutic

values of a new class of phytochemicals that are found in
plant foods consumed by humans.

The purpose of this study

was to observe the effects of the jasmonates on prostate
cancer cells cultured in vitro.

The jasmonates are plant

stress hormones derived from an omega-3 fatty acid
linolenic a c i d ) .

(alpha

Earlier studies by Fingrut and Flescher

[7] showed that the jasmonates possessed anticarcinogenic
effects against some cancer cell lines.

1.2

Significance of the study

This study is very significant since prostate cancer
still remains the second most common cause of cancer deaths
among men in the United States

[81.

It has been predicted

that 230,110 new cases and 29,900 deaths will occur in 2004
[81 .
Prostate cancer incidence rates are higher in African
American men compared to Caucasian men

[81 .

Table 1

compares prostate cancer death rate to that of other cancer
types;
cancer,

due to the number of deaths resulting from prostate
it is important that more studies be done in this

area which directly justifies the importance of this study.
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Table 1: Estimated new cancer cases and deaths in men,
2004. Adapted from ref. [8]
Cancer Type
Lung and bronchus
Prostate
Colon
Liver and
intrahepatic bile
duct
Melanoma-skin
Tongue
Brain and other
nervous system

US,

Estimated new
cases
93,110
230,110
50,400
12,580

Estimated deaths

29,900
7,320
1,130

5,050
1,100
110

1.3.

91,930
29,900
28,320
9,450

Epidemiology of Prostate Cancer

Prostate cancer is one of the leading causes of cancer
deaths among men in most developed countries,

yet only

little knowledge about its causal factors are known
Positive family histories of prostate cancer,

[91.

old age as

well as African ancestry have all been implicated as risk
factors for prostate cancer

[9].

However,

the risk for

development of prostate cancer may involve interactions of
two or more of these factors.
There are a number of new studies ongoing to identify
the risk factors involved with this disease such as the
influence of polyunsaturated fatty acid on prostate cancer
progression

[10]; however,

more studies are required to

confirm what the role of these polyunsaturated fatty acids
are, with respect to cancer treatment

[10].
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Studies of migrant Asian men done by Shimizu et al.
[11]

showed that environmental,

dietary,

or social factors

may be involved with the etiology of prostate cancer

[11].

They discovered that when migrant workers moved from a lowrisk country such as Japan to the United States,

there is

an increase in the incidence and mortality rate resulting
from prostate cancer and that this increase became several
folds higher than observed in their native Japanese
counterparts

[11].

In addition to that,

they found a

positive correlation between the number of years since
migration to the United States and incidence of prostate
cancer

ill].

They concluded that the increase in the

incidence may be related to the type of food consumed in
the United States such as a change in the diet from low fat
to high fat

[111.

The conclusion reached by Shimizu et al.

was later confirmed by Kakehi in 1998,

who studied the

epidemiology and clinical features of prostate cancer in
Japan and was able to show that high fat intake is
positively associated with increased risk and may in part,
explain the rising incidence of prostate cancer in Japan,
as dietary habits become more Westernized

[12].

Another risk factor that has been implicated with
the development and/or etiology of prostate cancer is
family history.

It was reported by Schuurman et al.
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in

1999 that men with prostate cancer are two to three times
more likely to have at least one first- or second-degree
relative with prostate cancer

[131.

et al. made their suggestions,

Even before Schuurman

Keetch et al.

in 1995 showed

that a patient with prostate cancer is between 3.1 to 4.3
times more likely than a control to have a history of
prostate cancer in his father and brothers,

respectively

[14 1 .
The role of vasectomy in prostate cancer progression
remains controversial.

Although retrospective and

prospective cohort epidemiological studies have
demonstrated a relative risk of approximately 1.6 in men
who underwent vasectomy

[15] other studies

[161 did not

confirm this.
Finally the molecular mechanisms of the disease as
well as the role of specific gene activity however remain
largely unsolved and continue to be an area of active
research

[101 .

1.4.

Classification of Prostate Cancer

Prostate cancer,

like other types of cancers,

develops

via a multi-stage carcinogenesis process with three
distinct phases:

initiation,

[[reviewed in 17]1.

promotion,

and progression

At the initiation phase,

the tumor is

7
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difficult to detect clinically,

due to its microscopic

nature at this stage and it is confined to the prostate but
undetectable by digital rectal examination
ultrasound or by any other screening method
1 7] J.

At the promotion phase,

(DRE),
[[reviewed in

the tumor which is already

in the prostate gland can be detected by DRE or ultrasound
[ [reviewed in 17]].
development,

In the final stages of prostate cancer

the cancer cells may have spread to organs

close to the prostate,
other lymph nodes,
prostate

such as the bladder,

organs,

or bones distant from the

[reviewed in 17].

Cancer Facts and Figures,

the pelvic and

According to the American
Prostate cancer can be classified

into four stages:
Stage I or Stage A: The tumor cannot be felt during a
rectal examination.

It may be found by accident during

surgery for other reasons such as benign prostatic
hyperplasia

(BPH).

Stage II or Stage B : The tumor involves more tissue within
the prostate and therefore can be felt during a rectal
exam,

or detected with a biopsy.

Stage III or Stage C : The tumor has spread outside of the
prostate to nearby tissues.
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stage IV or Stage D; At this stage of development,

the

tumor must have spread to the lymph nodes and/or to other
distant parts of the body

[8].

This proposed research will evaluate the effects of
plant stress hormones on prostate cancer cell lines
and DU-145)

obtained from the American Type cell culture

(ATCC; Mannasas,

1.5

(PC-3

VA).

Influence of hormone on prostate cancer progression.
Androgens are steroid hormones whose production

requires stimulation by leutinizing hormone and follicle
stimulating hormone from the pituitary gland
13).

Once produced,

(Figure 1, pg

androgen stimulates the prostate gland

by binding to a steroid receptor protein known as androgen
receptor

(AR)

[18].

This receptor is found in the nucleus

of the epithelial cells
Usually,

[181.

when androgen binds to its receptor

(AR), it

stimulates proliferation of the cells and diverts prostate
cancer cells from undergoing apoptosis

[18].

This was

documented in an earlier study by Kyprianou and Isaacs in
1998

[19] using rodent models.

They showed that when there

is a decrease in the amount of circulating androgens,
prostate cancer cells start undergoing apoptosis

[19].

This idea is the basis for hormone ablation therapy
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[18].

However,

when prostate tumor cells are deprived of hormone,

treatment only last for a while before the cancer cells
develop resistance to hormone
androgen independence thus,

[19]. This often leads to

making it more difficult to

regulate tumor cell growth using hormone ablation.

This

transformation from hormone-dependent to hormoneindependent tumor has been linked to many factors including
change in the androgen receptor gene expression.
testes produce testosterone
dihydrotestosterone

[18].

The

(T), and also

(DHT) which is the active metabolite of

T. 5-alpha reductase converts T to DHT which is directly
involved in prostate cancer progression

(Figure 1; pg 13}.

1.6

Apoptosis

The term "apoptosis" was devised by Kerr et al.

[21]

in 1972 to represent the type of cell death known as
"programmed cell death".

This distinguished apoptotic from

other types of cell death such as necrosis and oncosis
(cell death resulting from tumor formation and
characterized by swelling)

[21].

Change in the cell

morphology has been one way used to differentiate apoptotic
from non-apoptotic cells.

Cells undergoing apoptosis are

characterized by cell shrinkage,
fragmentation,

cellular budding and

and chromatin condensation

[21].

Apart from

10
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programmed cell death,

apoptotic death can also result from

physical and toxic exposures to chemicals or radiation and
cellular effects of cytokines such as tumor necrosis factor
[reviewed in 22].

This indicates that multiple pathways of

cell death may lead to similar morphological features

found

in typical apoptotic cells. Although it appears as if
apoptosis may involve multiple pathways,

it is still

possible to make a strong case for a final common pathway
for apoptosis since bcl-2 can still protect cells against
apoptosis induced by some of these stimuli
22].

[reviewed in

Bcl-2 may be protecting cells against apoptosis via

the inhibition of a central step involved in apoptosis or
protecting an important constituent of the cell that is a
target of apoptotic program

[reviewed in 22].

Other features of apoptosis such as the
externalization of phosphatidylserine from the inner to the
outer membrane of the cell plasma membrane have been
employed to quantify the number of apoptotic cells in a
cell population.

Annexin V-FITC has the ability to bind to

the externalized phosphatidylserine at the onset of
apoptosis

[231.

Apoptotic cells also show fragmented DNA,

this property is again very useful in the study of
apoptosis.

Assay such as BrdU are used to stain the

fragmented DNA,

also DAPI dye can be used to stain the

1
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fragmented DNA.

BrdU stains the 3-OH end of the DNA and

DAPI stains the double stranded DNA

[24,

25].

Hoechst and

propidium iodide are also dyes used in detecting apoptosis
in cells.

Propidium iodide stains necrotic cells thereby

helping in differentiating apoptotic cells from necrotic
cells.

On the other hand,

Hoechst stains live cells and so

differentiates them from apoptotic cells

[26].

The

greatest benefit of the study of apoptosis is that it has
led to the discovery of new genes and their effects in
regulating apoptosis

[reviewed in 221.

12
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Hypothalamus

Luetinizing hormone-releasing hormone

Pituitary
gland
Follicle stimulating and
luteinizing hormone

drenal gland

Testes

Androgen

Testosterone
5-alpha reductase

Dihydrotestosterone

Dihydrotestosterone
receptor (located in
the nucleus of the
epithelial cells.

Cell
signaling
pathway
Prostate cancer cell

Prostate cancer cell proliferation

Figure 1: The influence of hormones on prostate cancer cell
proliferation.

[Adapted from ref.20]

13
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1.7

Brief description of the cell lines

There are three prostate cancer cell lines that are
commonly used in research;

DU-145,

PC-3 and LNCap.

DU-145

and PC-3 are hormone-independent cell lines while LNCap
cell line is hormone-dependent.

Prostate cancer cells

usually progress from hormone-dependent to hormoneindependent stages,

thus,

hormone-independent prostate

cancers are more difficult to treat because the growth of
the cancer cells can no longer be regulated using hormone
[6].

We studied the effects of the jasmonates on prostate

cancer cell lines DU-145 ad PC-3 cultured in vitro.

PC-3

is a human epithelial prostate cancer cell line of grade IV
prostate cancer

[27].

It is an adherent cell line and has

a doubling time of about 18 hr.

DU-145 is also a human

prostate adenocarcinoma cell line;
cell line just like PC-3

[27].

it is also an adherent

The cell lines were

procured from the American Type cell culture
Mannasas,

VA).

cell lines,

(ATCC;

Many studies have been done using these

some of the known facts about these two human

prostate cancer cell lines are summarized in Table 2.
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Table 2: Facts about prostate cancer cell lines
DU-145) .
Cell

p53

p2l

Bcl-2

Ba:<

tetinoblas
toma (RB;

Cell

PC-3

n egative
[281

10hydroxycampto
thecin caus e d
e;-:pression of
p21
(29j

Wi Idtype
Bcl-2
e::press
ion [30]

Null
[31]

E x p ressed
p RB [32]

As 0.
ar rested
cell
grow t h of
PC-3 in
G_/M [34]

i n h i b i t i o n of
mouse
do u b l i n g
minute 2
(MDM2)
e:-:pression
r e sulted in
e x p r e s s i o n of
p21 [29]

wildtype
Bcl-2
express

Null

DU145

mutant
(28]

[31]

Neg a t i v e
[33]

[30]

cycle arrest

A s 0,
arr e s t e d
cell
g r owth of
D U-1 4 5
G.,/M [34]

ter azos i n
-induced
G, /G

(PC-3 and

5-HETE

IL-t

50unM made
cells grow
rapid!y
[30]

Expressed
[31!

Not

Expressed
[37]

[35]

terazosin
-induced
G.yoi

reported

[35]

PC-3 is also known to express heat shock transcription
factor 1 (HSF-1) [38].

1.8
The jasmonates
cis-jasmone
(MJ)

(CJ),

Jasmonates
(Figure 2; pg 17),

jasmonic acid

(JA)

consisting of

and methyl jasmonate

are a novel class of plant compounds first isolated

from the jasmine plant,

are natural bioregulators

[39] and

are involved in intracellular signaling and defense in
plants in response to injury

[40,

41].

The jasmonates were

reported to cause the formation of a zone of dead cells
around an infection site and the synthesis and accumulation
of antimicrobial agents

[42].

The layers of dead cells

that surround the site of pathogen entry or wounding are
thought to function as a physical barrier that inhibits
further proliferation and spread of the pathogen

[42].

Other roles for the jasmonates in plants include:

the

inhibition of processes such as growth and germination.

15
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promotion of senescence,
ripening,

abscission,

pigment formation,

tuber formation,

tendril coiling,

fruit

and others

I4 11 .
(personal communication)

Recent studies by Fingrut

showed that cis-jasmone induced cell death in some cancer
cell lines.

In addition,

analogs of cis-jasmone

acid and methyl jasmonate)

inhibited the proliferation and

induced cell death in lymphoblastic leukemia
breast cancer

(MCF7)

(jasmonic

(MOLT-4)

and

cells cultured in vitro but did not

affect normal human blood lymphocytes or erythrocytes

[7].

They also reported that JA and MJ caused apoptotic death,
as determined by morphological changes that accompany
apoptosis as well as caspase-3 activity.

In addition,

"the

jasmonates induced mitochondrial membrane depolarization as
determined by flow cytometry"

[7].

The jasmonates are synthesized in plants from alpha
linolenic acid through the lipoxygenase pathway
pq 18)

[43].

(Figure 3,

As shown in figure 3, the pathway starts with

the stimulation of a membrane receptor which results in the
activation of phospholipase

(PhD).

This is followed by the

release of alpha-linolenic acid which is further converted
to 13-hydroperoxylinolenic acid by lipoxygenase enzyme.
The formation of 12-oxo-phytodienoic acid marks the end of
jasmonate biosynthesis in the chloroplast.

The 12-oxo-
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phytodienoic acid then leaves the chloroplast to act as
signal in the peroxisome.

In the peroxisome,

12-oxo-

phytodienoic acid undergoes a reduction reaction catalyzed
by 3 - O X O - 2 (2 p e n t e n y l )-cyclopentane-l-octanoic acid as well
as beta-oxidation reaction leading to the formation of
jasmonic acid

(Figure 3, pg 18).

Jasmonic acid can then be

methylated by S- adenosyl-L-methionine:jasmonic acid
carboxylmethyltransferase to form methyl jasmonate or
undergo decarboxylation reaction to form the cis-jasmone
V1:1 g U X'G

J/ pQ

I.d )

COOH
cis-Jasmone

CJ

Jasmonic acid

COOCH
Methyl jasmonate

(MJ)

Figure 2: Structures of the jasmonates
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(JA)

COOH

alpha-Linolenic
acid

lipoxygenase 2

H0|
Plastid

13-hydroperoxylino
lenic acid

COOH

allene oxide synthase
COOH

allene oxide

allene oxide cyclase

COOH

c i s - (+)-12-oxophytodienoic
acid (OPDA)

OPDA reductase
3-OXO-2 (2
pentenyl)-cyclope
ntane-l-octanoic

Cytoplasm
COOH

acid

(0PC8)

Beta-oxidation
Peroxisome ?

'COOH

Decarboxylation

\ jasmonic acid methyl tarnsferase

COOCH]

Z)-jasmone

Methyl jasmonate

Figure 3: Model for the octadecanoid biosynthetic pathway
following wounding or pest attack.

Adapted from ref. [40] .
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1.9

5-Lipoxygenase pathway

As shown in Figure 4, pg 21,

the 5-lipoxygenase

pathway begins with the intracellular release of
arachidonic acid,

mediated by phospholipase A

(PLA,)

[reviewed in 44].

In leukocytes,

[45]

Clark et al.

that cytokines such interleukin-1

(IL-1)

showed

and tumor necrosis

factor can activate PLA] by stimulating a phospholipaseactivating protein

[45].

Once released,

arachidonic acid can either pass

through the cyclooxygenase pathway and get converted to
prostaglandin or it can pass through the action of 5-,
or 15-lipoxygenases into the corresponding HETEs
pg 21).

5-lipoxygenase in the presence of FLAP

activating protein)

12-,

(Figure 5 ;

(5-LO

catalyzes the oxygenation of

arachidonic acid into 5-hydroperoxyeicosatetraenoic acid
(5-HPETE),

followed by a second reaction in which 5-HPETE

is reduced in a glutathione-dependent reaction to 5hydroxyeicosatetraenoic acid

(5-HETE)

[reviewed in 441.

Recent study on the localization of 5-lipoxygenase
enzyme showed that it varies depending on the cell type
[reviewed in 44].
the nucleus
cytosol

[46],

[47],

For example,

in B-cells,

in HL-60 cells,

and in RBL

it is found in

5-LO is found in the

(rat basophilic leukemia),

situated in both the nucleus and the cytosol

[47].
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it is
5-

lipoxygenase has also been shown to move from one area of
the cell to the other.

For instance,

polymorphonuclear leukocytes

(PMNs),

in human
5-lipoxygenase

translocates from the cytosol to the nuclear membrane when
activated with Ca^^ [reviewed in 44].
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Phospholipids
stimulus

Phospholipase A

COOH
20
11

14

5,8,11,14-Eicosatetraenoic acid

(Arachidonic acid)

5 -Lipoxygenase
OOH
COOH

20

11

14

5 - Hydroperoxyeicosatetraenoic acid

(5-HPETE]

Glutathione dependent reaction
OH
COOH

20

11

14

5-Hydroxy-eicosatetraenoic acid

(5-HETE)

Figure 4 : Lipoxygenase pathway showing the conversion of
arachidonic acid

(C20:

4) into 5 -HETE. Adapted from ref

[441

21

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

PGH,

-*■ TXB,

I n h i b i t o r s - I n d o m et haci n,
pir oxica m, a s p i r i n
Cyclooxygenase

A r a c h i d o n i c acid-

-►
E p o x y g e n a s e (cyt p-450)

t po xygen ase
metabolites

Inh ibito rs -AA851, MK886,
E i c o s a t e c r a y n o i c aci d
Inhibitors -baicalein and BHP?

5- H E T E

12-HETE
leukotrienes

Figure 5: The eicosanoid pathway.
[48,

49,

50,

51,

Adapted from ref.

52].

Studies linking the eicosanoid pathway to prostate
cancer progression have been documented.
linoleic acid

For example,

(a precursor of arachidonic acid)

stimulated

cell growth in experiments conducted by Rose and Connolly
[48] using human prostate cancer

(PC-3 and DU- 1 45)c e l l s ,

whereas indomethacin,

and piroxicam

inhibitors)

esculetin,

(Figure 5) inhibited it,

(eicosanoid

indicating the

involvement of eicosanoids in prostate cancer cell
proliferation

However,

later studies by Anderson et
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al.

[49]

showed that cyclooxygenase

indomethacin and aspirin,
PC3 cell DNA synthesis,
antagonist,

(COX)

inhibitors

failed to reduce human prostate

although the arachidonic acid

eicosatetraynoic acid,

did reduce synthesis,

suggesting that LG products are essential in modulating
prostate DNA synthesis

[49].

Other studies done by Anderson et al.
with the specific 5-LO inhibitor

(A63162),

[50]

showed that

there was

reduction in DNA synthesis and growth inhibition of
prostate cancer

(PC-3)

cells,

this also supports the

involvement of the LO metabolic pathway in prostate cancer
growth

[50].

Recent study done by Ghosh and Myers

[51]

using PC-3 cells provides convincing evidence that the 5-LO
metabolic pathway stimulates prostate cancer cell growth,
they confirmed this by adding selective inhibitors of the
different metabolic pathways of arachidonic acid such as
SKF-525A for cytochrome P-450,
cyclooxygenase,

ibuprofen for

baicalein and BHPP for 12-lipoxygenase,

AA861 and M K 886 for 5-lipoxygenase and found that only the
5-LO specific inhibitors were able to inhibit the
proliferation of PC-3 cells

[51].

In another study,

both

M K -886 and AA-861 which are 5-lipoxygenase inhibitors
blocked prostate tumor proliferation induced by arachidonic
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acid, whereas the COX inhibitor ibuprofen and 12-LO
inhibitors baicalein and BHPP were ineffective
On the basis of this information,

[52].

agents that directly

or indirectly interfere with the synthesis of lipoxygenase
metabolites may be effective in preventing cancer.
However,

recent studies have shown that some phytochemicals

especially those that are derived from omega-3

fatty acids

inhibit the activities of 5-lipoxygenase and thereby
function as both anticancer and anti-inflammatory agents
[53].

Indeed,

research into the possible role of

phytochemicals especially the omega-3 dérivâtes in the
treatment of cancer has been promising.

Hypothesis
The hypothesis being tested in this thesis is whether
jasmonates inhibit the proliferation and induce cell death
in prostate cancer cells in vitro and if so what will be
the possible pathway for the induction of cell death.

These

findings will identify a novel group of plant compounds for
the prevention and/or therapy of prostate cancer in humans.
The model proposed to directly test these hypotheses
is shown in Figure 6 .
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1.10

Proposed Model

The model proposed for this research was to study the
effect of jasmonates on the proliferation of prostate
cancer cells cultured in vitro and to propose a possible
pathway through which these plant stress hormones elicit
their effects.
Therefore,

to test our hypothesis,

we used both

proliferation and cytotoxicity assays as well as apoptosis
assays.

We also,

used the 5-lipoxygenase enzyme to trace

the proposed pathway

(Figure 6 ).

5-lipoxygenase
A ra chidonic acid

5-HPETE

jasmonates

5-HETE

Increased PC-3 cell proliferation

Figure 6 : Proposed pathway model for jasmonate inhibition
of prostate cancer cells.
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CHAPTER 2

2.1

MATERIALS

2.1.1
Jasmonic acid
acid],

Chemicals and Reagents

[3 - o x o - 2 {2 - p e ntenyl) cyclopentaneacetic

cis-Jasmone

methyl jasmonate

[3 - o x o - 2 (2 - p e ntenyl) c y c lopentane], and

[methyl 3-oxo- 2( 2- p e n t e n y l )

cyclopentaneacetic acid],

3-(4,

5-dimethyl-2-thiazolyl)-2,

5-diphenyl-2H- tétrazolium bromide
dye, propidium iodide

(PI)

St Louis,

dye,

Hoechst 33258

and 4 ' , 6-diamidino-2-

phenylindole hydrochloride
Chemical Co.,

(MTT)

(DAPI)

MO.

were purchased from Sigma

Annexin V-FITC and BrdU assay

kits were purchased from BD Biosciences PHARMINGEN,
Diego,
CA,

(San

C A ) , 5-lipoxygenase was obtained from CalBiochem,

Fetal bovine serum

Laboratories,

(Logan,

(FBS)
UT)

was purchased from Hyclone

and penicillin/streptomycin

(P/S)

was obtained from Invitrogen Incorporated(Grand Island,
NY).

Minimum essential medium

(MEM Eagle)

and Ham's F-12K

medium were purchased from the American Type culture
collection

(ATCC; Manassas,

VA).

Stock solutions

each jasmonate were prepared by dissolving in
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(l.OM)

of

dimethylsulfoxide

(DMSO), filter-sterilized and the

aliquots stored at -20°C prior to use.
2.1.2

Cells and cell culture

Prostate adenocarcinoma

(DU-145 and PC-3)

cell lines

were purchased from the American Type Culture Collection
(ATCC, Manassas,

VA).

DU-145 cells were cultured in

Minimum Essential Medium

(Eagle's modification)

cells were cultured in HAMS F-12K medium.

while PC-3

Each growth

medium was supplemented with 10% FBS and 1% penicillinstreptomycin.

2.2
2.2.1

Methods

Cytotoxicity and Proliferation Assays

The cytotoxic effect of each agent was evaluated using
the dye exclusion assay
and clonogenic assays.

(DEA), mitochondrial dehydrogenase
The DEA measures the integrity of

the cell membrane by measuring the permeability of the
membrane to trypan blue,

a charged molecule.

Cells with an

intact membrane exclude the charged dye while cells with
compromised membrane take up the dye.
cells/plate)

Cells

(1 million

were cultured in 60-mm tissue culture plates

and allowed to adhere overnight at 37 C in a humidified,
C O 2a t m o s p h e r e .
jasmonate

5%

The cells were treated with methyl

(MJ), cis-jasmone

(CJ)

or jasmonic acid
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(JA)

at

concentrations ranging from 0-3mM.

For the treatment,

the

medium in each plate was aspirated off and replaced with
the appropriate treatment medium and incubated at 37 C in 5%
C O 2 for 24 hr.

At the desired time period,

harvested and counted using a hemacytometer.

cells were
Live and dead

cells were counted separately and the total number of live
cells was determined.

Cell viability was calculated as a

percentage of live cells in the treatment groups relative
to the control

(100%) .

2.2.2 Mitochondrial Dehydrogenase Assay

(MTT)

The MTT assay measures the activity of mitochondrial
dehydrogenase,
cells

[54].

an enzyme present in live but not in dead

Briefly,

cells

(5,000/well)

were cultured in

96-well tissue culture plates overnight to adhere and then
treated with concentrations

(0.5-3mM)

of CJ, MJ or JA in

lOOpl of medi u m for up to 72 hr.

The control cells

received medi u m with DMSO

v/v).

(^0.1%,

the agent for a specified period of time,

After exposure to
the treatment

medium was aspirated off and replaced with lOOpl of fresh
complete m e d i u m and lOpl of MTT

(5mg/ml)

in each well and

the plate incubated at 37°C in a humidified,
atmosphere for 3 hr.

The formazan crystals formed were

solubilized with lOOyl of the stop solution
iso p r o p a n o l ) .

5% CO;

The optical densities

(CD)

(O.IN HCl in

of the resulting
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solutions were determined at 570nm with a reference at
630nm using a microplate reader
Meriden,

CT).

Cell viability

(Packard Instruments,

(%) was calculated by

comparing the OD of the treatment group relative to that of
the control cells

(100%).

Percent viability was taken as a

measure of the cytotoxicity of each agent.

2.2.3 Colony Formation Assay

(CFA)

The long-term effect of the jasmonates on the
proliferation of prostate cancer cells was also assessed by
using colony formation assay
[ij.

Briefly,

cells

(CFA)

(500/well)

as previously described

were cultured in 6-well

plates and allowed to adhere for 12-18 hr.
day,

The following

the culture medium was removed and replaced by control

or treatment medium
incubated for 24 hr.

(containing 0.5 or l.OmM)

and the cells

At the end of the incubation period,

cells were rinsed twice with phosphate bovine serum

(PBS),

once with complete culture medium and then incubated in
complete culture medium for up to 14 days.

The plates were

viewed under the microscope every other day to monitor cell
growth.

At termination,

each well;

the growth medium was removed from

the cells were washed with sterile PBS,

stained with crystal violet
Colonies,

and then

(0.5g/100ml in 95% ethanol).

each containing at least 50 cells,

were counted
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and the cell proliferation was assessed by comparing the
number of colonies formed in the treatment group to that of
the control

(1 0 0 %).

2.2.4

Apoptosis Assays
Flow Cytometric Analyses

2.2.4.1

To determine the effects of the jasmonates on cell
cycle progression and apoptosis,

cells in exponential

growth were treated with or without the jasmonates

for

specified period of time and analyzed by flow cytometry.
Cells

(100,000/plate)

were cultured in 100mm tissue culture

plates overnight to adhere.

The cells were then exposed to

control or varying concentrations
72 hr.

(0.5-3mM)

At the end of the exposure period,

harvested,

rinsed with PBS,

For DNA content analysis,
DNA staining solution
Img/ml RNase A

cytometer

the cells were

and fixed with 90% ethanol.

the cells were re-suspended in

(150pg/ml PI:

(DNase-free)

1:1:1 by volume)

of MJ for up to

0.1% Triton-X 100:

in PBS lacking Ca^* or Mg^"^;

and analyzed using a FACSCalibur flow

(Becton Dickinson,

San Jose,

fluorescence was linearly amplified,

CA).

PI

and both the area and

width of the fluorescence pulse were measured using
CellQuest acquisition software
CA).

(Becton Dickinson,

Twenty thousand events were acquired and the
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San Jose,

percentages of hypodiploid

(apoptotic;

populations and cells in Go/Gi,

sub-Go/Gi)

S or Gg-M phases were

determined using ModFit LT version 3.0 analysis software
(Verity Software House,

Inc.,

Topsham,

ME).

2. 2. 4.2 Microscopic determination of apoptosis.
To confirm the mode of cell death,

changes in the

morphology of treated and control cells were analyzed using
dual

(Hoechst and PI)

to control or MJ,

or DAPI staining.

cells

Following exposure

(50,000/w e l l ) plated in 12-well

plates were washed three times with PBS and stained with
Hoechst
(5pg/ml)

(Ipg/ml)

for 5 min and then with propidium iodide

for 10 min at room temperature.

Hoechst dye

stained live or dying cells while PI stained dead cells.
To further confirm apoptosis,
above were fixed,

cells treated as described

on ice, with 3% paraformaldehyde and 0.1%

Triton X-100 in PBS for 1 hr.
10 min with DAPI

(Ipg/ml)

Fixed cells were stained for

in distilled,

de-ionized water.

Changes or alterations in nuclear morphology were observed
and photographed with a fluorescence microscope
Eclipse TE2000-U,

equipped with a UV2A filter)

(Nikon
to determine

the presence or absence of essential morphological
characteristics such as chromatin condensation and
fragmentation,

a hallmark of apoptosis.
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2.2.4.3 Annexin V-FITC
The transversion of phosphatidylserine from the inner
to outer plasma membrane leaflet,

an initial event in the

apoptotic pathway was assessed by dual dye staining using
Annexin V-FITC/PI.

Briefly,

DU-145 and PC-3 cells

(2 X 10*)

were cultured in 100mm dishes in the appropriate medium and
allowed to adhere overnight,
and cells exposed for 72 hr.

after which 2mM MJ was added
At the end of exposure time,

both the untreated and treated cells were harvested and
washed with cold PBS and then pelleted for 5 minutes at
400xg.

The number of cells was adjusted to approximately

500,000 cells per ml in PBS before pelleting.

Cells were

washed in 2.0 mL of 1 x Annexin-V Binding Buffer
PHARMINGEN,

San Jose,

CA)

for 5 minutes,

centrifuged at

500Xg and then treated with Annexin-V-EITC
San Jose,

CA)

(BD

(BD PHARMINGEN,

and incubated in the dark for 15 minutes.

The volume of cells-conjugated mixture was adjusted up with
addition of 450pL of 1 x Annexin-V binding buffer,

(each

tube contains cells-conjugate mixture of approximately
500pL).

Acquisition to discriminate between apoptotic and

necrotic or dead cells was done by staining the cellsconjugate mixture with lOpL PI
PHARMINGEN,

San Jose,

CA).

(500pg/mL)

solution

(BD

Acquisition was done on BD's

FACSCalibur Cytometer on the FLl

(Annexin)

and FL3
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(PI)

channels with threshold on FSC and Duplet Discriminating
Module

(DDM)

set at FLl.

The level of shift in events

distribution in the treated cells stained with Annexin-V
only and Annexin-V-PI populations in comparison to
untreated controls is indicative of level of apoptosis that
can be induced by MJ.

Numeric quantitations of these

events were accomplished with population gating.
case,

In each

10,000 events were analyzed by flow cytometry.

2. 2. 4. 4 Terminal deoxynucleotide transferase
dUTP nick-end labeling

(TdT)-mediated

(TUNEL)

Apoptotic cells were visualized using DeadEnd
colorimetric detection system

(Phoenix Flow System Inc.,CA)

according to the manufacturer's instructions.
cells

(2x10*)

Briefly,

of Jurkat T-l y m p h o c y t e , DU-145 or PC-3 were

fixed with formaldehyde to retain

(crosslink)

fragmented

DNA within apoptotic cells and the 3 'OH termini of DNA
strand breaks were labeled with BrdUTP

(this is a reaction

catalyzed by the terminal deoxynucleotidyl transferase)
while cellular DNA was counterstained with PI.

Jurkat T-

lymphocyte cells were used in this study as internal
control for the two prostate cancer cell lines.

The green

and red fluorescence of cells probed for DNA strand breaks
and DNA content was measured using 488 nm laser excitation
in FACSCalibur flow cytometer

(Becton Dickinson,

San Jose,
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CA).

To calculate the proportion of cells in the

respective phases of the cell cycle,

the DNA content

frequency histograms were deconvoluted using the Multicycle
software
shown).

(Phoenix Flow Systems,

San Diego,

CA)

(data not

Most experiments were run in triplicate and the

experiments were repeated.
2.2.4.5

Mechanism of Inhbition

Since we proposed that the jasmonates may be
inhibiting prostate cancer cell proliferation via the
lipoxygenase pathway,
assay,

briefly;

96-well plate.

we tested this model using the MTT

PC-3 cells

(10,000/well)

were plated in a

Cells were allowed to adhere overnight and

the m e dium was then aspirated off.

Cells were exposed to

treatment m e d i u m containing 0 .0 0 0 1 , 0 .0 0 1 , 0 .0 1 , 0 .1 , or 1
Units

(U) of 5-lipoxygenase enzyme only;

0.01,

0.1,

or 1 Units

0.0001,

0.001,

(U) of 5-lipoxygenase enzyme

supplemented with 2mM methyl jasmonate;
jasmonate only or untreated
end of the exposure time,

(control)

2mM methyl

for 72 hr.

At the

the treatment medium was

aspirated off and replaced with lOOpl fresh medium and lOpl
MTT dye.

Cell viability was assessed as described on pg
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2.3

Statistical Analysis

Results were expressed as mean ±S.D.
analyses.

Data analyses were performed

using ANOVA for a three factor,

of replicate

(where appropriate)

factorial treatment model

with one way blocking to examine the effects of the three
factors and differences at the many levels within each
factor.

The effectiveness of concentration levels compared

to control was determined by Dunnet's two-sided test while
Turkey's LSD was used to analyze the effects of MJ on the
proliferation of human prostate adenocarcinoma cells at
different concentration levels using multiple comparisons.
Differences with p-value <0.01 were considered
statistically significant.
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Chapter 3

3.1

RESULTS AND DISCUSSION

We performed cytotoxicity and proliferation assays
using DEA,

MTT and clonogenic

(CFA)

techniques to determine

the effects of the jasmonates on the proliferation of
prostate cancer cells in culture.
jasmonates on cell viability,

as measured using trypan blue

are as shown in Figure 7; pg 46.
3mM of agent

(CJ, JA or MJ)

The effects of

Exposure of cells up to

resulted in a dose-dependent

decrease in the total number of live cells
percentage of viable c e l l s ) .

In DU-145,

(as well as

MJ at 3mM showed

about 50% inhibiton compared to JA treated group and about
50% inhibition of proliferation compared to CJ treated
group.

Both CJ and JA did not show much effect in DU-145

cell.

However,

inhibitions
JA

(15%)

with PC-3 cells at 3mM,

for the three agents are MJ

the percent
(35%),

CJ

(20%)

and

These results indicate that the jasmonates

inhibit the proliferation of these prostate cancer cells at
the conditions used during these experiments with MJ
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significantly

(p<0 .0 1 ) causing the greatest effect at

lowering the number of live cells.
The cytotoxicity of the jasmonates on the
proliferation of DU-145
9; pg 48)
assay.

(Figure 8 ; pg 47) and PC-3

(Figure

cells in culture were assessed using the MTT

The MTT assay measures the activity of

mitochondrial dehydrogenase;
only active in live,

a class of enzymes that are

but not in dead cells.

Therefore a

decrease in the proliferation of the prostate cancer cells
is a measure of the cytotoxicity of the agent(s)
tested.

MJ significantly

(p<0.01)

being

inhibited the

proliferation of both cell lines compared to CJ or JA at
2mM except at 24hr

(Figures 8 and 9; pg 47-48).

The

effective dose of MJ that inhibited cellular proliferation
by 50%

(ED50) at 24,

for PC-3 cells
DU-145 cells
exposure,

48,

or 72 hr were 1.6,

(Table 3; pg 58)

(Table 3; pg 58),

and 2.8,

1.1,

2.3,

respectively.

and 0. 5mM

and 2.0 for
At 72 hr of

a comparison of the ED 50 showed that PC-3 cells

(ED5o=0 .5mM)

were significantly

MJ than DU-145 cells

(p<0.01)

(EDso=2.O m M ) .

more sensitive to

Both CJ and JA minimally

suppressed the proliferation of DU-145 cells

(Figure 8 ; pg

47), however CJ showed about 50% inhibition at 72 hr with
PC-3 cells

(Figure 9; pg 48),

JA did not show much effect

after exposure for 48 or 72 hr.

Also Figures 8 and 9,
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(pg

4 7 to 48)

indicate that at 3mM concentration of MJ,

all the cells were killed.

Therefore,

almost

concentrations

ranging from 0-lmM were used to study the long term effects
of these agents on the proliferation of human prostate
cancer cells.
The long-term effects of exposure of PC-3 and DU-145
cells to jasmonates on proliferation of the cells were
studied using colony formation assay.

MJ at ImM

concentration inhibited the proliferation of DU-145 cells
by 80%
pg 49;.

(p<0.01)

compared to the control cells

(Figure 10;

Equivalent concentrations of CJ or JA caused 30

and 15% inhibition of proliferation in DU-145 cells
respectively

(Figure 10; pq 49).

In PC-3 cells,

both MJ

and CJ inhibited proliferation by approximately 50-60%
while JA caused about 30% inhibition of proliferation
(Figure 10; pg 4 9).
CJ significantly

Compared to control cells,

(p< 0.01)

and JA

(p< 0.05)

long-term proliferation of PC-3 cells
In earlier reports,
human leukemia
and breast

(MCF7)

prostate

inhibited the

(Figure 10; pg 49).

the effects of JA and MJ

(Molt-4),

both MJ and

(0.5-3mM)

(LNCap), melanoma

(SK28),

cells cultured in vitro was studied

The highest concentration

on

[7].

(3mM) was equivalent to the

highest non-toxic pharmacological concentration of the non
steroidal anti-inflammatory agent,

salicylic acid
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(SA),

used in humans

[55].

Fingrut and Flescher reported that MJ

was the most effective when compared to JA or SA at
inducing cell death in every cell line studied.
concentration,

MJ reduced the viability of Molt-4,

SK28 and MCF7 cells by approximately 90,

70,

[71.

that at 2mM,

MJ reduced the viability of LNCap,

MCF7 cells by 35,
[71.

LNCap,

40 and 35%

respectively

exposure

At 3mM

Further examination of their data showed
SK28 and

15 and 10% respectively after 24 hr

Our results,

demonstrating the effectiveness

of MJ on the prostate adenocarcinoma cell lines PC-3
1.6mM)

and DU-14 5

(ED50 = 2.8mM)

at 24 hr

(ED50 =

(Figure 10; pg 4 9)

compared very favorably with the results obtained earlier
[7] for the exposure of the prostate adenocarcinoma cell
line

(LNCap)

to MJ.

In addition,

our results showed that

MJ was the most effective among the jasmonates in eliciting
cytotoxic effect on prostate cancer cells,

therefore,

only

MJ was employed to further study the mechanism of
inhibition of proliferation of prostate cancer cells in
culture.

Since MJ was the most studied of all the

jasmonates in this research,

comparing the percent

inhibition observed from dye exclusion,
formation assays,

in DU-145 cells,

MTT and colony

using dye exclusion,

at 3mM showed 50% inhibition at 24 hr compared to the
untreated group;

with MTT assay,

MJ at 3mM,

showed about
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MJ

55% inhibition at 24 hr compared to the untreated group in
DU-145 cells.

In PC-3 cells,

dye exclusion result showed

about 30% inhibition of MJ at 3mM,

where as MTT assay

showed 90% inhibition after 24 hr exposure.

This

descripancy in percent inhibition can be explained by the
fact that while dye exclusion assay measures the ability of
the agent to inhibit proliferation,

MTT assay measures the

cytotoxicity of the agent being tested.
3.1.1

MJ induced cell cycle arrest and apoptosis.

Since MJ was more effective than CJ or JA as an
inhibitor of proliferation,

we investigated whether the

observed inhibition of proliferation was via the induction
of apoptosis.

We used flow cytometric methods to study the

effects of MJ on cell cycle progression and apoptosis in
prostate cancer cells exposed for up to 72 hr.

MJ caused

cell cycle arrest in the G2/M phase in DU-145 cells
4; pg 59).

In PC-3 cells,

(Table

MJ caused cell cycle arrest in

the S-phase arrest at 48 and 72 hr

(Table 4; pg 59).

The

cell cycle arrest was accompanied by increase in
hypodiploidy as the exposure time increased,
PC-3 cells,

although in

there was a reduction in apoptosis observed at

72 hr compared to 48 hr,

however,

this calls for more

studies so as to have a better understanding of what is
going on.

Plots of the apoptotic index

(which was
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calculated as a ratio of the mean values of sub-Go/Gi
populations of the treatment group relative to that of the
respective control)
Figure 11

(pg 50).

for the two cell lines are shown in
This apoptotic index plot date were

obtained from an earlier experiment which shows the same
trend as that seen in Table 4.
3.1.2

Confirmation of apoptosis

To confirm apoptosis,

we used dual

(Hoechst and PI)

staining of treated cells and fluorescence microscopy
techniques.
stain.

Live and dying cells fluoresced with Hoechst

When the same field was stained with PI and viewed

using the fluorescence microscope,
(Figure 12 & 13; pg 51-52)
necrotic cells.

dead cells fluoresced

suggesting that there are some

The Hoechst stain also indicated a

decrease in the cell population in the MJ-treated group
compared to the control

(Figure 12 & 13; pg 51-52).

stained the nuclei with DAPI dye,
and fragmentation were observed

When we

chromatin condensation

(Figure 14; pg 53)

which

confirmed that the observed cell death was via the
induction of apoptosis rather than necrosis.
Since apoptotic cells lose membrane phospholipid
asymmetry,

resulting in the externalization of

phosphatidylserine
membrane,

(PS) to the outer leaflet of the plasma

apoptosis is often quantified by measuring this
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PS externalization using Annexin V-FITC staining.

Annexin

V is often used in conjunction with vital dyes such as
propidium iodide

(PI), which bind to nucleic acids,

but can

only penetrate the plasma membrane when membrane integrity
is breached,
in necrosis.

as occurs in the later stages of apoptosis or
PI is a non-specific DNA intercalating agent,

which is excluded by the plasma membrane of living cells,
and thus can be used to distinguish necrotic cells from
apoptotic and living cells.
death

(apoptosis or necrosis)

To quantify the mode of cell
induced by MJ,

treated as described in chapter two
results

Annexin

^pg 32-33).

(Figures 15 6 16; pg 54-55),

(LL) ; Annexin

and PI"

and PI"^ (UR)

cells were
In the

Annexin V' and PI'

(LR) ; Annexin V" and PI"^ (UL) ;
represent live cells

apoptotic cells

(LR), necrotic cells

apoptotic cells

(UR)

respectively.

(LL) , early

(UL) and late

As shown in Figures 15 &

16; pg 54- 5 5 , treatment of human prostate adenocarcinoma
(DU-145 or PC-3)
the live

cells with 2mM MJ resulted in decrease in

(LL)cell population as well as increase in

apoptotic populations
respective controls
DU-145 cells,

(LR + UR)

when compared to their

(untreated groups).

For instance,

in

the result showed a decrease in the number of

live cells from 82.69% in the control to 49.76% in the
treated group with 1 1 .1% apoptotic cells in the control and
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33.49% apoptotic cells in the treated group.
trend was observed with PC-3 cells,

A similar

the number of live

cells decreased from 87.50% in the control group to 51.63%
in the treated group with 1 2 .02% apoptotic cell population
in the control and 37.74% apoptotic cell population in the
treated group.
To further confirm the induction of apoptosis by MJ on
these prostate cancer cells,

cells were treated and assayed

using Terminal deoxynucleotide transferase
dUTP nick-end labeling
chapter two

(pg 33-34).

(TUNEL)

(TdT)-mediated

assay as described in

The result

(Figure 17; pg 56)

shows

that MJ at 2mM caused a shift to the right of the
histograms in treated groups compared to the untreated
control.

Ml and M2 represent live and apoptotic cells

respectively.

These values were obtained using the method

described by Phoenix Flow System,

San Diego,

CA.

in which

the controls are used as templates to determine the level
of apoptosis in the treatment groups.

In DU-145 cells,

(Figure 17; pg 56) Ml was 90.94% while M2 was 9.20% in the
control,

however,

in the treated group.

50.83% with M2 showing 49.27%.

Ml showed about

In PC-3 cells,

(Figure 17;

pg 56) Ml was 91.16% and M2 was 8.95% in the untreated
group,

in the treated group,

increased up to 7 0.23%.

Ml decreased to 29.90% as M2

These sets of results

(Figure 17;
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pg 56)

confirmed that MJ induced apoptosis in these cancer

cells.

Jurkat T-Lymphocyte cells which were used as

internal control however,

showed about 8.18% apoptosis in

the control and 69.06% in the treatment group,

this does

not tell us much about the mechanism of inhibition caused
by MJ and so more studies are necessary to help elucidate
the possible m echanism of induction of apoptosis by MJ on
the two prostate cancer cell lines
3.1.3

(DU-145 and P C - 3 ) .
Mechanism of Inhibition

Figure 18; pg 57 shows that when PC-3 cells were
treated with 2mM MJ , there was an inhibition of about 90%,
however,

when the same concentration of MJ was supplemented

with different doses of 5-lipoxygenase,

5-LO was able to

stimulate the cells and thus reduce the inhibitory effects
of MJ on PC-3 cells.

This suggests that 5-lipoxygenase

affects the inhibitory effect of methyl jasmonate,

thus 5-

lipoxygenase pathway may have a role to play in the
proliferation of prostate cancer cell line
when cells were treated with 5-LO only,
inhibition rather than stimulation,

(PC-3). Also,

there was a slight

suggesting that 5-LO

might actually be affecting the chemical structure of MJ
thus reducing its

(MJ)

cells.

(Figure 18; pg 57) validates our earlier

The result

inhibitory effects on the cancer

proposal that MJ may be inhibiting the proliferation of
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prostate cancer cells and that 5-lipoxygenase may be
antagonist to MJ.
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Figure 7: Effects of jasmonates on the proliferation of
human prostate adenocarcinoma cells (DU-145 and PC-3)
exposed for 24 hr.
Jasmonic acid (JA), cis-jasmone (CJ)
and methyl jasmonate (MJ) inhibited the proliferation of
prostate cancer cells in a dose-dependent fashion with MJ
showing the greatest effect.
Error bars are so small as
not to be visible.
* p<0.01 for MJ versus either CJ or JA
at 2mM or 3mM. t p<0.05 for MJ at 3mM versus control for MJ
in the two cell lines
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Figure 8: Jasmonates-induced inhibition of proliferation of
DU-145 cells in culture using MTT assay.
JA and CJ showed
little or no inhibition of proliferation while MJ showed
the greatest effect.
The proportion of viable cells (Mean
± S.D.; n=12) was plotted against jasmonate concentrations
(mM). The figure is representative of at least three
separate experiments.
* P<0.01 for MJ versus either CJ or
JA at 3mM after 24, 48 or 72 hr of exposure. There were no
significant (p<0.01) difference between CJ and JA at all
concentrations and time points. There were no error bars in
the control since they were used to normalize the treatment
group.
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Figure 9: Jasmonate-induced inhibition of proliferation of
PC-3 cells in culture using MTT assay.
MJ elicited
cytotoxic effects on the cells.
CJ shows little effect
whereas JA shows no inhibition of proliferation even at 3mM
after 72 hr.
The concentrations of jasmonates that caused
50% inhibitions of proliferation are shown in table 3, pg
57.
* P<0.01 for MJ versus either CJ or JA at 2 or 3mM
after 24, 48 or 72 hr of exposure.
t p<0.05 for CJ versus
JA at 72 hr. There were no significant (p<0.05) difference
between CJ and JA at 24hr. There were no error bars in the
control since they were used to normalize the treatment
group.
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Figure 10: The jasmonates delayed the proliferation of
prostate cancer cells cultured in vitro.
Cells were
exposed to 0, 0.5 or l.OmM jasmonic acid (JA), cis-jasmone
(CJ) or methyl jasmonate (MJ) for 24 hr.
The treatment
medium was aspirated off and the cells were washed twice
with PBS and once with medium.
The complete medium was
added and the cells incubated for 14 days at 37°C in a
humidified, 5% CO2 atmosphere.
The cells were then washed,
and stained with crystal violet and the colonies counted.
Cell viability was calculated as a percentage relative to
the untreated (control) cells (100%).
Values plotted were
Mean ± S.D. (n=3) versus the concentration of jasmonates
(mM). The figure is representative of two separate
experiments.
* P<0.01 for MJ at 0.5 and ImM versus control
in D U - 1 4 5 .
Both MJ and CJ significantly (p< 0.01) and JA
(p< 0.05) inhibited the long-term proliferation of PC-3
cells.
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Figure 11: Methyl jasmonate (MJ) induced time-dependent
increase in sub- Go/Gi populations in prostate cancer cells
in culture.
Cells were treated in triplicates with 0 or
2mM MJ for 24, 48 or 72 hr, harvested, fixed, stained with
PI and analyzed using a FACSCalibur flow cytometer (Becton
Dickinson, San Jose, C A ) . The data were acquired as
described for Table 4 and the Apoptotic Index was
calculated as a ratio of the Mean values of sub-Go/Gi
populations of the treatment group relative to that of the
respective Control.
The figure represents a plot of the
Apoptotic Index (arbitrary units) versus exposure time.
The figure is representative of two separate experiments.
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Hoechst

Propidium iodide

b

Figure 12: Methyl jasmonate (MJ) in duced apoptosis in
prostate adenocarcinoma (DU-145) ce 11s in culture after 72
hr exposure.
Cells 50,000/well) we re double-stained with
Hoechst (Ipg/ml) and propidium iodi de (5pg/ml). The
fluorescence of live or dying cells (Hoechst fluorescence)
and dead cells (PI fluorescence) we re acquired using
fluorescence microscopy (Nikon TE 2 OOOU, Lake Forest, C A ) .
a, b and c correspond to untreated (control), ImM and 2mM
MJ respectively.
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Propidium iodide

Hoechst

b

Figure 13; Methyl jasmonate (MJ) induced apoptosis in
prostate adenocarcinoma (PC-3) cells in culture after 72 hr
exposure.
Cells 50,000/well) were double-stained with
Hoechst (Ipg/ml) and propidium iodide (5pg/ml). The
fluorescence of live or dying cells (Hoechst fluorescence)
and dead cells (PI;fluorescence) were acquired using
fluorescence microscopy (Nikon TE 2000U, Lake Forest, C A ) .
a, b and c correspond to untreated (control), ImM and 2mM
MJ respectively.
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Control

MJ

Figure 14: Methyl jasmonate induced nuclear fragmentation
in DU-145 cells.
Cells, both the control and treated group
were fixed in 3% paraformaldehyde and stained with DAPI for
10 minutes.
Changes in the nuclear morphology of the cells
were observed at 4 OX magnification and then photographed
using a fluorescence microscope.
Arrows show nuclear
chromatin condensation and fragmentation which are
hallmarks of apoptosis.
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Figure 15: DU-145 cells contour diagram of FITC-Annexin
V/PI flow cytometry of cells treated for 72 hr.
Untreated
and treated cells were harvested and washed with 5 ml wash
buffer.
Lower left quadrants (LL) of each point
show the viable cells.
The upper right quadrant (UR)
represents late apoptotic cells.
The lower right quadrants
(LR) represent the early apoptotic cells and the upper left
(UL) quadrant represents the necrotic cells.
2mM MJ was
used because at concentrations above 2mM the cells were
almost wiped out, and because 2mM MJ was used in most of
the assays as optimum concentration, it is necessary to be
consistent.
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Figure 16: PC-3 cells contour diagram of FITC-Annexin V/PI
flow cytometry of ceils treated for 72 hr.
Untreated and
treated cells were harvested and washed with 5 mi wash
buffer.
Lower left quadrants (LL) of each point
show the viable ceils.
The upper right quadrant (UR)
represents late apoptotic cells.
The lower right quadrants
(LR) represent the early apoptotic cells and the upper left
(UL) quadrant represents the necrotic cells.
2mM MJ was
used because at concentrations above 2mM the cells were
almost wiped out, and because 2mM MJ was used in most of
the assays as optimum concentration, it is necessary to be
cons ist ent .
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Figure 17: Jurkat T - l y m phocyte, PC-3 and DU-145 cell death
analysis using BrdUrd labelling. Untreated and treated
cells for 72 hr were harvested and washed with 5 ml of wash
buffer. Cells were incubated in DNA labelling for 1 hr at
37°C in water bath. After incubation, cells were rinsed
twice with 1.0ml rinsing buffer and resuspended in 0.1ml of
Fluorescein-PRB-1 Antibody solution for 30 minutes in the
dark. 0.5ml of propidium iodide/RNase A solution was added
and cells incubated for 30 minutes. Cell distribution was
analyzed using flow cytometry. Ml and M2 represents live
and apoptotic cells respectively. Jurkat cells were used as
internal control. The experiment was repeated twice.
2mM
MJ was used because at concentrations above 2mM the cells
were almost wiped out, and because 2mM MJ was used in most
of the assays as optimum concentration, it is necessary to
be consistent.
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FigurelS: Effect of 5-lipoxygenase on PC-3 cell growth.
1x10^ cells were plated per well of 96-well plate and
allowed to adhere overnight.
Cells were then stimulated
with different concentrations of 5-lipoxygenase only or 5lipoxygenase supplemented with 2mM MJ and exposed for 72
hr.
Cells were then stained with alamar blue dye.
Absorbance was taken at excitation of 590nm and emission
wavelength of 530nm.
Data are the mean ± SO (N=4). * No
significant (p<0.05) difference between 5-LO at lU versus
control in the 5-LO-only treated group.
t p<0.01 for MJonly treated group versus control and ¥ P<0.05 for MJ-only
treated group versus MJ supplemented with lU 5-LO.
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Table 3: Concentration of MJ (mM) that inhibited
proliferation of PC-3 or DU-145 cells by 50% (IC50).

Cell line
PC-3
DU-145

Agent
MJ
MJ

24 hr
IC50(mM)
1.6
2.8

4 8 hr
IC50(mM)
1.1
2.3

72 hr
IC50(mM)
0.5
2.0

58

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 4: Effects of methyl jasmonate (MJ) on PC-3 and DU145 cells in culture
DU-145
PC-3
S
G z /M
s
Gz/M
Sub-Go/Gi
G
O
/G
l
Sub-Go/G 1
Treatment
GVG,

24H r

Control

2 .0 m M

48H r

Control

2 .0 m M

72H r

Control

2 .0 m M

51.7
± 1 .4

59.7
± 5 .4

33 8

14.5

± 1 .0

± 0.7

26.1

14.2

± 9 .0

± 3 .6

0.01
± 0 .0 2

5h6
± 1 .4

14.5
± 0 .6

16.2

0.01

±1.1

± 0 .2

0.15
± 0.1

633

16.2

263

0.14

± 2 .0

±0 .3

± 2 .7

± 0 .1

56.1

263

17.6

0.01

526

15.3

9.1

0.84

± 1 .0

± 0 .6

± 0 .4

± 0 .0

±0.1

± 0 .6

± 0 .9

±0.1

545
±2^

622

20J

± 1 .0

± 0 .4

273
±63

±0 .3

54 2
±25

34J
±2 .5

10.9
± 0 .6

56 4

25^

± 1 .0

± 0 .2

51.8

37.4

10.8

± 0 .6

± 0 .5

± 0 .1 2

17.9
± 0 .9

0.01
± 0 .0

689

563

13.3

6.6

038

± 0 .7

±1 .3

±0.1

± 0 .6

11.0

0.03

528

17.5

203

± 0 .0 2

± 1 .6

±1.1

±2.1

± 0 .8

Prostate adenocarcinoma cells (PC-3 & DU-145) were treated
with jasmonate (MJ) for 24-72 hr. The cells were harvested,
fixed with ethanol, stained with propidium iodide and
analyzed for cells in different phases of the cycle using a
FACSCalibur flow cytometer. Values are MeaniSD of
triplicate analyses. The experiment was performed twice.

59

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Chapter 4

4.1 CONCLUSION
The jasmonates inhibited the proliferation of human
prostate adenocarcinoma cells in culture.

MJ was the most

potent of the three members of this class significantly
inhibiting proliferation and inducing cell death.

Although

CJ showed some cytotoxic effects against PC-3 cells
9; pg 48},

(Figure

it did not show much inhibition of proliferation

or induce cell death in DU-145 cells at the concentrations
tested

(Figure 8; pg 47).

the jasmonates
CJ or MJ.

JA was the least effective of

(Figure 8 and 9; pg 47-48)

when compared to

These results are in agreement with Fingrut and

Flescher who reported that MJ was a more potent inhibitor
of proliferation than JA in human leukemia
(MCF7)

and prostate

(LNCap)

(MOLT-4),

cancer cells in culture

breast
[7j.

MJ was reported to be relatively non-toxic to whole
animals.

Fingrut and Flescher administered MJ

body weight)

(236 mg/kg

intraperitoneally to mice daily for 30 d a y s .

They found that "this dose,

and even a two times higher
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dose,

did not cause any apparent toxic effect".

These

researchers also reported that there were no changes in the
activity level,

feeding and appearance of the treated mice

compared to the controls

[7] .

We confirmed using flow cytometry,
tunnel

(BrdU)

Annexin V-FITC,

and fluorescence microscopy assays that the

mechanism for the observed inhibition of proliferation of
prostate cancer cells by MJ was via cell-cycle arrest and
the induction of apoptosis.
experimental

[36]

Epidemiological

[56,

571

and

studies have indicated a link between

arachidonic acid metabolism and the proliferation of human
prostate adenocarcinoma cells.

Arachidonic acid,

its conversion to 5-hydroxyeicosatetraenoic acid

through
(5-HETE)

in the lipoxygenase pathway strongly stimulated the growth
of hormone-responsive

(LNCaP)

and hormone-refractory

human prostate cancer cell lines in culture

[361.

(PC-3)

5-

L i p o x y g e n a s e , a key enzyme in the synthesis of 5-HETE,
over expressed in prostate adenocarcinoma cells
[58].

Furthermore,

was

(PC-3)

the inhibition of arachidonate 5-

lipoxygenase activity by the specific inhibitor MK886
blocked 5-HETE production and induced apoptosis in human
prostate cancer cells

(PC-3)

[36].

Both the inhibition of

lipoxygenase activity by MK886 and the induction of
apoptosis in prostate cancer cells were reversed by the
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addition of 5-HETE

[36].

Since MJ is a downstream product

of the lipoxygenase pathway in plants

[43], we proposed

that the m e chanism of action of MJ may involve the
inhibition of the lipoxygenase pathway,

however,

our

results show slight inhibition of cells when treated with
5-lipoxygenase as shown in our results
in human prostate cancer cells.
the synthesis of 5-HETE,

(Figure 18; pg 57)

Such inhibition would block

an important compound needed for

the survival and proliferation of the prostate cancer
cells.

[36]

4.2

Recommendation for future study

Having confirmed that these agents,

especially MJ,

inhibited the proliferation of human prostate
adenocarcinoma cells via the induction of apoptosis,

it

would be pertinent to investigate the cellular and
molecular mechanisms that are involved in the response of
prostate cancer to MJ.

This can be achieved by studying the

effects of jasmonates on the synthesis of 5-HETE,
proposed a 5-HETE dependent pathway

since we

(figure 6, pg 25),

if

COX inhibitors are applied to these prostate cancer cell,
we would think that there will be cell stimulation as
already confirmed in an earlier study

[361,

since

arachidonic acid will all be diverted to the lipoxygenase
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pathway,

therefore,

since we proposed that MJ would inhibit

the synthesis of 5-HETE,

addition of MJ would reduce the

stimulatory effects of 5-HETE on the cell.

Also this 5-HETE

can be quantified to give a better understanding of whether
MJ is inhibiting its synthesis of not.

It will also be

important to study the role of p53 in MJ-induced apoptosis
in prostate cancer cells,

however,

it has been reported

earlier that PC-3 for instance lack p53

[26],

it is still

worth studying to know if MJ can cause p53 expression in
these cancer cells.

Finally,

the roles of other pro and

anti-apoptotic proteins such as Bcl-2,

Bax,

Rb,

Bcl-x etc.

will be necessary to look into since that will help to
elucidate the proper mechanism/pathway involved in these
rea c t i o n s .
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